GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Zantac has been owned by different drugmakers in its more than 30-year run as one of the most popular antacids in the US. The ...

GSK spin-off Haleon has come into the crosshairs as it now controls the drugmaker's consumer health business - although it says it is not a party to any of the Zantac claims.

(Bloomberg) -- GSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars from the laboratory that revealed the presence of a probable carcinogen in Zantac, the ...

GSK’s shares rose by as much as 6.5% on Thursday before settling back slightly lower after it ... drugmaker’s now-discontinued heartburn drug Zantac triggered cancer. The agreement was much ...